Similar articles

• Localized perineal cutaneous nodules: a case of recurrent systemic anaplastic large-cell lymphoma.

  Hernandez C, Puangsuvan SN, Peterson A, Robinson JK. Hernandez C, et al. Clin Exp Dermatol. 2009 Dec;34(8):e722-5. doi: 10.1111/j.1365-2230.2009.03448.x. Clin Exp Dermatol. 2009. PMID: 20055841
• Long-term bexarotene monotherapy in large cell CD30+ pleomorphic T-cell lymphoma.

  Aldaoud A. Aldaoud A. Dermatol Clin. 2008 Jan;26 Suppl 1:15-7. Dermatol Clin. 2008. PMID: 18405181 No abstract available.
• Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.

  Shehan JM, Kalaaji AN, Markovic SN, Ahmed I. Shehan JM, et al. J Am Acad Dermatol. 2004 Jul;51(1):103-10. doi: 10.1016/j.jaad.2003.12.028. J Am Acad Dermatol. 2004. PMID: 15243534 Review.
• Folliculotropic mycosis fungoides with CD30+ large-cell transformation in a young woman: beneficial effect of bexarotene.

  Mitteldorf C, Stadler R, Bertsch HP, Neumann C. Mitteldorf C, et al. Br J Dermatol. 2007 Mar;156(3):584-6. doi: 10.1111/j.1365-2133.2006.07672.x. Br J Dermatol. 2007. PMID: 17300259 No abstract available.
• The optimal use of bexarotene in cutaneous T-cell lymphoma.

  Gniadecki R, Assaf C, Bagot M, Dummer R, Duvic M, Knobler R, Ranki A, Schwandt P, Whittaker S. Gniadecki R, et al. Br J Dermatol. 2007 Sep;157(3):433-40. doi: 10.1111/j.1365-2133.2007.07975.x. Epub 2007 Jun 6. Br J Dermatol. 2007. PMID: 17553039 Review.